265 related articles for article (PubMed ID: 17223963)
41. Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature.
Antinori S; Calattini S; Longhi E; Bestetti G; Piolini R; Magni C; Orlando G; Gramiccia M; Acquaviva V; Foschi A; Corvasce S; Colomba C; Titone L; Parravicini C; Cascio A; Corbellino M
Clin Infect Dis; 2007 Jun; 44(12):1602-10. PubMed ID: 17516404
[TBL] [Abstract][Full Text] [Related]
42. Expression of human leukocyte antigen-G in systemic lupus erythematosus.
Rosado S; Perez-Chacon G; Mellor-Pita S; Sanchez-Vegazo I; Bellas-Menendez C; Citores MJ; Losada-Fernandez I; Martin-Donaire T; Rebolleda N; Perez-Aciego P
Hum Immunol; 2008 Jan; 69(1):9-15. PubMed ID: 18295670
[TBL] [Abstract][Full Text] [Related]
43. Soluble serum HLA-G in children with allergic rhinitis and asthma.
Ciprandi G; De Amici M; Caimmi S; Marseglia A; Marchi A; Castellazzi AM; Marseglia G
J Biol Regul Homeost Agents; 2010; 24(2):221-4. PubMed ID: 20487636
[TBL] [Abstract][Full Text] [Related]
44. Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders.
Sebti Y; Le Maux A; Gros F; De Guibert S; Pangault C; Rouas-Freiss N; Bernard M; Amiot L
Br J Haematol; 2007 Jul; 138(2):202-12. PubMed ID: 17593027
[TBL] [Abstract][Full Text] [Related]
45. Nucleoside reverse transcriptase inhibitors are able and protease inhibitors unable to induce the tolerogenic molecule HLA-G1 on monocytes from HIV-1 infected patients.
Rivero A; Lozano JM; González R; García-Jurado G; Camacho A; Torres-Cisneros J; Peña J
Hum Immunol; 2007 Apr; 68(4):303-6. PubMed ID: 17400067
[TBL] [Abstract][Full Text] [Related]
46. Soluble HLA-G changes in maternal blood serum during the progression of labor.
Knafel A; Basta P; Pitynski K; Mach P; Bednarek W; Klimek M; Zietek J; Zajac K; Dancewicz L; Iwaniec M; Basta A; Wicherek L
Neuro Endocrinol Lett; 2009 Mar; 30(1):67-73. PubMed ID: 19300382
[TBL] [Abstract][Full Text] [Related]
47. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
[TBL] [Abstract][Full Text] [Related]
48. Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage.
Fainardi E; Rizzo R; Lupato A; Ramponi V; De Santis G; Garofano F; Stignani M; Tamborino C; Castellazzi M; Casetta I; Baricordi OR
Acta Neurochir Suppl; 2010; 106():141-5. PubMed ID: 19812937
[TBL] [Abstract][Full Text] [Related]
49. Impact of blood processing on estimation of soluble HLA-G.
Poláková K; Bandžuchová E; Russ G
Neoplasma; 2011; 58(4):337-42. PubMed ID: 21520991
[TBL] [Abstract][Full Text] [Related]
50. Comparison of soluble and membrane bound HLA-class I and DR levels in umbilical cord blood and adult peripheral blood.
Higuchi A; Hagihara M; Tsumuraya N; Gansuvd B; Kato S; Hotta T
Tokai J Exp Clin Med; 2003 Apr; 28(1):1-7. PubMed ID: 12880297
[TBL] [Abstract][Full Text] [Related]
51. Immunomodulatory effects of blood transfusions: the synergic role of soluble HLA Class I free heavy-chain molecules detectable in blood components.
Ghio M; Contini P; Ubezio G; Mazzei C; Puppo F; Indiveri F
Transfusion; 2008 Aug; 48(8):1591-7. PubMed ID: 18466172
[TBL] [Abstract][Full Text] [Related]
52. [Relationship between HLA antigens and the HIV infection in patients from the state of Zulia].
Hassanhi MS; Rivera SE; Fuenmayor AM; Márquez GC; Salas D; de Avila LM; Sanabria A; de Ruiz Z
Sangre (Barc); 1995 Apr; 40(2):109-13. PubMed ID: 7784939
[TBL] [Abstract][Full Text] [Related]
53. A novel sandwich ELISA for alpha1 domain based detection of soluble HLA-G heavy chains.
Juch H; Blaschitz A; Daxböck C; Rueckert C; Kofler K; Dohr G
J Immunol Methods; 2005 Dec; 307(1-2):96-106. PubMed ID: 16310801
[TBL] [Abstract][Full Text] [Related]
54. Potential role of soluble human leukocyte antigen-G molecules in multiple sclerosis.
Fainardi E; Rizzo R; Castellazzi M; Stignani M; Granieri E; Baricordi OR
Hum Immunol; 2009 Dec; 70(12):981-7. PubMed ID: 19651179
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
Rasmussen M; Dahl M; Buus S; Djurisic S; Ohlsson J; Hviid TV
Tissue Antigens; 2014 Aug; 84(2):206-15. PubMed ID: 24785939
[TBL] [Abstract][Full Text] [Related]
56. Embryonic soluble HLA-G as a marker of developmental potential in embryos.
Noci I; Fuzzi B; Rizzo R; Melchiorri L; Criscuoli L; Dabizzi S; Biagiotti R; Pellegrini S; Menicucci A; Baricordi OR
Hum Reprod; 2005 Jan; 20(1):138-46. PubMed ID: 15498780
[TBL] [Abstract][Full Text] [Related]
57. [Gastrointestinal leishmaniasis in patients infected with the human immunodeficiency virus].
Laguna F; Soriano V; Valencia E; González-Lahoz JM
Rev Clin Esp; 1994 Jun; 194(6):510-1. PubMed ID: 8079027
[No Abstract] [Full Text] [Related]
58. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
[TBL] [Abstract][Full Text] [Related]
59. The possible anti-inflammatory role of circulating human leukocyte antigen levels in women with endometriosis after treatment with danazol and leuprorelin acetate depot.
Matalliotakis IM; Athanassakis I; Goumenou AG; Neonaki MA; Koumantakis EE; Vassiliadis S; Koumantakis EE
Mediators Inflamm; 2001 Apr; 10(2):75-80. PubMed ID: 11405553
[TBL] [Abstract][Full Text] [Related]
60. Visceral leishmaniasis in HIV-infected patients in the south of France.
Dereure J; Reynes J; Pratlong F; Lamaury I; Rioux JA; Janbon F; Dedet JP
Bull World Health Organ; 1995; 73(2):245-6. PubMed ID: 7743597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
